Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.

Huang K, D'Souza D, Patil N, Velker V, Leung E, Stitt L, Whiston F, Sugimoto A, McGee J, Prefontaine M.

Brachytherapy. 2016 Sep-Oct;15(5):543-8. doi: 10.1016/j.brachy.2016.06.010. Epub 2016 Jul 27.

PMID:
27475479
2.

Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?

Velker V, D'Souza D, Prefontaine M, McGee J, Leung E.

Int J Gynecol Cancer. 2016 Mar;26(3):491-6. doi: 10.1097/IGC.0000000000000643.

PMID:
26825823
3.

TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.

Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.

Endocr Relat Cancer. 2016 Mar;23(3):147-59. doi: 10.1530/ERC-15-0383. Epub 2015 Dec 8.

4.

Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.

Peart T, Ramos Valdes Y, Correa RJ, Fazio E, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.

Oncotarget. 2015 Sep 8;6(26):22424-38.

5.

CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.

D'Souza D, Wiebe E, Patil N, Sugimoto A, Prefontaine M, Aulakh S, Whiston F, Stitt L, Surry K.

Brachytherapy. 2014 May-Jun;13(3):225-32. doi: 10.1016/j.brachy.2014.02.001. Epub 2014 Mar 5.

PMID:
24613570
6.

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.

Correa RJ, Valdes YR, Peart TM, Fazio EN, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.

Carcinogenesis. 2014 Sep;35(9):1951-61. doi: 10.1093/carcin/bgu049. Epub 2014 Feb 22.

7.

Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers.

Belhocine TZ, Prefontaine M, Lanvin D, Bertrand M, Rachinsky I, Ettler H, Zabel P, Stitt LW, Sugimoto A, Urbain JL.

Am J Nucl Med Mol Imaging. 2013;3(2):182-93. Epub 2013 Mar 8.

8.

Complete uterine inversion in a patient with endometrial cancer.

Préfontaine M.

J Obstet Gynaecol Can. 2012 Jul;34(7):609. English, French. No abstract available.

PMID:
22742476
9.

Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature.

Vilos GA, Marks J, Ettler HC, Vilos AG, Prefontaine M, Abu-Rafea B.

J Minim Invasive Gynecol. 2012 May-Jun;19(3):288-95. doi: 10.1016/j.jmig.2011.12.025. Review.

PMID:
22546421
10.

Choriocarcinoma in an AIDS patient--relapsing but not fatal.

Shah AM, Tidswell M, Prefontaine M, Skiest DJ, Pantanowitz L.

Int J STD AIDS. 2008 Jul;19(7):496-8. doi: 10.1258/ijsa.2007.007133.

PMID:
18574129
11.

Cystic struma ovarii (with macrocystic change).

Piragua SC, Otis CN, Prefontaine M, Pantanowitz L.

Int J Surg Pathol. 2008 Oct;16(4):433-4. doi: 10.1177/1066896908315752. Epub 2008 Apr 7.

PMID:
18397898
12.

Cholelithiasis of the ovary after laparoscopic cholecystectomy: a case report.

Pantanowitz L, Prefontaine M, Hunt JP.

J Reprod Med. 2007 Oct;52(10):968-70.

PMID:
17977178
13.

Vernixuria: another sign of uterine rupture.

O'Grady JP, Prefontaine M, Hoffman DE.

J Perinatol. 2003 Jun;23(4):351-2.

14.

Clinical notebook. Nursing assessment turns life around.

Prefontaine MM, Fahey KE.

Alta RN. 2000 Jul-Aug;56(4):26-7. No abstract available.

PMID:
11309901
15.

Blindness as a consequence of a paraneoplastic syndrome in a woman with clear cell carcinoma of the ovary.

Donovan JT, Prefontaine M, Gragoudas ES.

Gynecol Oncol. 1999 Jun;73(3):424-9.

PMID:
10366472
16.

Mesenteric small-bowel polyposis: a diagnostic radiographic sign of neurofibromatosis.

Seppala R, Préfontaine M, Mikhael NZ.

AJR Am J Roentgenol. 1997 Feb;168(2):434-6. No abstract available.

PMID:
9016221
17.

Treatment of refractory ovarian cancer with 5-fluorouracil and leucovorin.

Préfontaine M, Donovan JT, Powell JL, Buley L.

Gynecol Oncol. 1996 May;61(2):249-52.

PMID:
8626142
18.

Uterine tumor in the heart: intravenous leiomyomatosis.

Steinmetz OK, Bedard P, Prefontaine ME, Bourke M, Barber GG.

Surgery. 1996 Feb;119(2):226-9. No abstract available.

PMID:
8571211
19.

Referral patterns for suspected ovarian cancer: a survey of practicing gynecologists.

Préfontaine M, Gruslin A.

Int J Gynecol Cancer. 1995 Sep;5(5):381-385.

PMID:
11578508
20.

Reproducibility of tumor measurements in ovarian cancer: a study of interobserver variability.

Préfontaine M, Gelfand AT, Donovan JT, Powell JL.

Gynecol Oncol. 1994 Oct;55(1):87-90.

PMID:
7959274
21.

A pilot study of intra-arterial carboplatin in patients with recurrent carcinoma of the cervix, postradiation.

Verma S, Prefontaine M, Bertrand M, Genest P, Dahrouge S.

Gynecol Oncol. 1994 Jun;53(3):290-3.

PMID:
8206400
22.

Cytoreductive surgery for ovarian cancer with the Cavitron Ultrasonic Surgical Aspirator and the development of disseminated intravascular coagulation.

Donovan JT, Veronikis DK, Powell JL, Lundy LE, Préfontaine M.

Obstet Gynecol. 1994 Jun;83(6):1011-4.

PMID:
8190415
23.

Vaginal probe ultrasound in malignancy involving the uterine cervix.

Prefontaine M, Demianczuk N.

Eur J Gynaecol Oncol. 1993;14(6):455-60.

PMID:
8181484
24.

A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies.

Kuesel AC, Kroft T, Saunders JK, Préfontaine M, Mikhael N, Smith IC.

Magn Reson Med. 1992 Oct;27(2):349-55.

PMID:
1461119
25.

Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease.

Kuesel AC, Kroft T, Préfontaine M, Smith IC.

Int J Cancer. 1992 Sep 30;52(3):341-6.

PMID:
1399109
26.

The clinicopathological significance of cytomegalovirus inclusions demonstrated by endocervical biopsy.

Byard RW, Mikhael NZ, Orlando G, Cyr RM, Prefontaine M.

Pathology. 1991 Oct;23(4):318-21. Review.

PMID:
1664515
27.

Comparison of topical Xylocaine with placebo as a local anesthetic in colposcopic biopsies.

Prefontaine M, Fung-Kee-Fung M, Moher D.

Can J Surg. 1991 Apr;34(2):163-5.

PMID:
2025805
28.

Evaluation of a simple line width test involving magnetic resonance spectroscopy of plasma in carcinoma of the ovary.

Prefontaine M, Kroft T, Monck M, Saunders JK, Mikhael NZ, Smith IC.

Cancer. 1991 Jan 15;67(2):406-11.

PMID:
1985735
30.

Gallstone ileus masquerading as recurrent carcinoma of the ovary.

Prefontaine M, Hardy M, Genest P.

Gynecol Oncol. 1990 Oct;39(1):89-92.

PMID:
2227579
31.

Obstructive ureteropathy following radiation therapy for carcinoma of the cervix.

Parliament M, Genest P, Girard A, Gerig L, Prefontaine M.

Gynecol Oncol. 1989 May;33(2):237-40.

PMID:
2703184
32.

Prognostic significance of endometrial extension in carcinoma of the cervix.

Grimard L, Genest P, Girard A, Gerig L, Prefontaine M, Drouin P, Nair RC, Stats M.

Gynecol Oncol. 1988 Oct;31(2):301-9.

PMID:
3169619
33.

Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.

O'Connell GJ, Ryan E, Murphy KJ, Prefontaine M.

Obstet Gynecol. 1987 Dec;70(6):930-2.

PMID:
3479735
34.

Prognostic factors in early carcinoma of the endometrium.

Genest P, Drouin P, Gerig L, Girard A, Stewart D, Prefontaine M.

Am J Clin Oncol. 1987 Feb;10(1):71-7.

PMID:
3825996

Supplemental Content

Loading ...
Support Center